Symphoria 2021-2022

In recent years, the Drug Discovery Industry has seen remarkable developments and rapid progress. The global market for drug discovery technologies should grow from $69.8 billion in 2020 to $110.4 billion by 2025 with a compound annual growth rate (CAGR) of 9.6% for the period of 2020-2025. In addition, bioinformatics, cheminformatics, and molecular modelling are expected to reduce the annual cost of developing a new drug by 33% and the time it takes to discover a new drug by 30%.

The outbreak of COVID-19 led to a temporary halt in clinical trials of drug discovery for several diseases as the healthcare sector, researchers, and academia focused on curtailing COVID-19. This symposium on Emerging Trends in Drug Discovery and Development aims to bring together leading industry professionals, scientists, researchers to exchange and share their knowledge and experiences on various aspects of the drug discovery process. It will provide an interdisciplinary platform for industry and academia to present and discuss the recent innovations, trends, and concerns as well as practical challenges encountered and solutions implemented in this field.

The symposium will also throw light on the new and upcoming areas like Machine Learning and their applications in the drug discovery process. Overall, the participants will benefit with the sharing of information in the varied scientific disciplines implemented to address the numerous aspects and challenges encountered in drug discovery, design and development.